Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Y-mAbs Therapeutics, Inc. | Director | Common Stock | 5.83K | $69.9K | $12.00 | Jun 11, 2024 | Direct |
Y-mAbs Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 14.5K | Jun 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
YMAB | Y-mAbs Therapeutics, Inc. | Jun 8, 2023 | 2 | $0 | 4 | Jun 9, 2023 | Director |
YMAB | Y-mAbs Therapeutics, Inc. | Jul 15, 2022 | 1 | $0 | 4 | Jul 19, 2022 | Director |
YMAB | Y-mAbs Therapeutics, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |